• Je něco špatně v tomto záznamu ?

Nitroglycerin to Ameliorate Coronary Artery Spasm During Focal Pulsed-Field Ablation for Atrial Fibrillation

Y. Malyshev, P. Neuzil, J. Petru, M. Funasako, P. Hala, K. Kopriva, C. Schneider, A. Achyutha, A. Vanderper, D. Musikantow, M. Turagam, SR. Dukkipati, VY. Reddy

. 2024 ; 10 (5) : 885-896. [pub] 20240221

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24014163

BACKGROUND: In treating atrial fibrillation, pulsed-field ablation (PFA) has comparable efficacy to conventional thermal ablation, but with important safety advantages: no esophageal injury or pulmonary vein stenosis, and rare phrenic nerve injury. However, when PFA is delivered in proximity to coronary arteries using a pentaspline catheter, which generates a broad electrical field, severe vasospasm can be provoked. OBJECTIVES: The authors sought to study the vasospastic potential of a focal PFA catheter with a narrower electrical field and develop a preventive strategy with nitroglycerin. METHODS: During atrial fibrillation ablation, a focal PFA catheter was used for cavotricuspid isthmus ablation. Angiography of the right coronary artery (some with fractional flow reserve measurement) was performed before, during, and after PFA. Beyond no nitroglycerin (n = 5), and a few testing strategies (n = 8), 2 primary nitroglycerin administration strategies were studied: 1) multiple boluses (3-2 mg every 2 min) into the right atrium (n = 10), and 2) a bolus (3 mg) into the right atrium with continuous peripheral intravenous infusion (1 mg/min; n = 10). RESULTS: Without nitroglycerin, cavotricuspid isthmus ablation provoked moderate-severe vasospasm in 4 of 5 (80%) patients (fractional flow reserve 0.71 ± 0.08). With repetitive nitroglycerin boluses, severe spasm did not occur, and mild-moderate vasospasm occurred in only 2 of 10 (20%). Using the bolus + infusion strategy, severe and mild-moderate spasm occurred in 1 and 3 of 10 patients (aggregate 40%). No patient had ST-segment changes. CONCLUSIONS: Ablation of the cavotricuspid isthmus using a focal PFA catheter routinely provokes right coronary vasospasm. Pretreatment with high doses of parenteral nitroglycerin prevents severe spasm.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014163
003      
CZ-PrNML
005      
20240905134322.0
007      
ta
008      
240725s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jacep.2023.12.015 $2 doi
035    __
$a (PubMed)38385916
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Malyshev, Yury $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
245    10
$a Nitroglycerin to Ameliorate Coronary Artery Spasm During Focal Pulsed-Field Ablation for Atrial Fibrillation / $c Y. Malyshev, P. Neuzil, J. Petru, M. Funasako, P. Hala, K. Kopriva, C. Schneider, A. Achyutha, A. Vanderper, D. Musikantow, M. Turagam, SR. Dukkipati, VY. Reddy
520    9_
$a BACKGROUND: In treating atrial fibrillation, pulsed-field ablation (PFA) has comparable efficacy to conventional thermal ablation, but with important safety advantages: no esophageal injury or pulmonary vein stenosis, and rare phrenic nerve injury. However, when PFA is delivered in proximity to coronary arteries using a pentaspline catheter, which generates a broad electrical field, severe vasospasm can be provoked. OBJECTIVES: The authors sought to study the vasospastic potential of a focal PFA catheter with a narrower electrical field and develop a preventive strategy with nitroglycerin. METHODS: During atrial fibrillation ablation, a focal PFA catheter was used for cavotricuspid isthmus ablation. Angiography of the right coronary artery (some with fractional flow reserve measurement) was performed before, during, and after PFA. Beyond no nitroglycerin (n = 5), and a few testing strategies (n = 8), 2 primary nitroglycerin administration strategies were studied: 1) multiple boluses (3-2 mg every 2 min) into the right atrium (n = 10), and 2) a bolus (3 mg) into the right atrium with continuous peripheral intravenous infusion (1 mg/min; n = 10). RESULTS: Without nitroglycerin, cavotricuspid isthmus ablation provoked moderate-severe vasospasm in 4 of 5 (80%) patients (fractional flow reserve 0.71 ± 0.08). With repetitive nitroglycerin boluses, severe spasm did not occur, and mild-moderate vasospasm occurred in only 2 of 10 (20%). Using the bolus + infusion strategy, severe and mild-moderate spasm occurred in 1 and 3 of 10 patients (aggregate 40%). No patient had ST-segment changes. CONCLUSIONS: Ablation of the cavotricuspid isthmus using a focal PFA catheter routinely provokes right coronary vasospasm. Pretreatment with high doses of parenteral nitroglycerin prevents severe spasm.
650    _2
$a lidé $7 D006801
650    12
$a fibrilace síní $x chirurgie $7 D001281
650    12
$a nitroglycerin $x aplikace a dávkování $x terapeutické užití $7 D005996
650    12
$a koronární vazospasmus $x prevence a kontrola $7 D003329
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a ženské pohlaví $7 D005260
650    12
$a katetrizační ablace $x metody $x škodlivé účinky $7 D017115
650    _2
$a senioři $7 D000368
650    _2
$a vazodilatancia $x terapeutické užití $x aplikace a dávkování $7 D014665
650    _2
$a koronární angiografie $7 D017023
650    _2
$a koronární cévy $x účinky léků $x chirurgie $x patofyziologie $7 D003331
655    _2
$a časopisecké články $7 D016428
700    1_
$a Neuzil, Petr $u Homolka Hospital, Prague, Czech Republic
700    1_
$a Petru, Jan $u Homolka Hospital, Prague, Czech Republic
700    1_
$a Funasako, Moritoshi $u Homolka Hospital, Prague, Czech Republic
700    1_
$a Hala, Pavel $u Homolka Hospital, Prague, Czech Republic
700    1_
$a Kopriva, Karel $u Homolka Hospital, Prague, Czech Republic
700    1_
$a Schneider, Christopher $u Farapulse-Boston Scientific, Inc, Menlo Park, California, USA
700    1_
$a Achyutha, Anitha $u Farapulse-Boston Scientific, Inc, Menlo Park, California, USA
700    1_
$a Vanderper, Annelies $u Farapulse-Boston Scientific, Inc, Menlo Park, California, USA
700    1_
$a Musikantow, Daniel $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
700    1_
$a Turagam, Mohit $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
700    1_
$a Dukkipati, Srinivas R $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
700    1_
$a Reddy, Vivek Y $u Icahn School of Medicine at Mount Sinai, New York, New York, USA; Homolka Hospital, Prague, Czech Republic. Electronic address: vivek.reddy@mountsinai.org
773    0_
$w MED00193518 $t JACC. Clinical electrophysiology $x 2405-5018 $g Roč. 10, č. 5 (2024), s. 885-896
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38385916 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134316 $b ABA008
999    __
$a ok $b bmc $g 2143759 $s 1226029
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 10 $c 5 $d 885-896 $e 20240221 $i 2405-5018 $m JACC. Clinical electrophysiology $n JACC Clin Electrophysiol $x MED00193518
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...